• KemPharm Receives $10M Milestone Payment for FDA Approval of AZSTARYS™ americanpharmaceuticalreview
    April 23, 2021
    KemPharm, Inc. has announced receipt of a regulatory milestone payment of $10 million for the FDA approval of AZSTARYS™ in accordance with the recently amended definitive collaboration and license agreement with Commave Therapeutics, SA, an affiliate ...
PharmaSources Customer Service